NICE changes rules for end-of-life treatments
This article was originally published in Scrip
Executive Summary
Patients in England and Wales who are expected to die within two years may be considered for more expensive life-extending treatments in the national health service than has been the case until now. The National Institute for health and Clinical Excellence(NICE) has published new guidance on the circumstances in which its cost-effectiveness rules can be set aside for end-of-life patients.